OncoMatch/Clinical Trials/NCT06940947

Endoscopic Therapy Or Surgery for Early Colon Cancer

Is NCT06940947 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies non-drug interventions for colon cancer.

Phase 3RecruitingNorwegian Department of Health and Social AffairsNCT06940947Data as of Jun 2026Location: Poland

The trial is a randomized head-to-head comparison of the benefits, harms and burdens of endoscopic full-thickness resection (eFTR), a novel, minimally invasive endoscopic treatment modality, for early colon cancer as compared to standard-of-care surgery.

Check if I qualify

Extracted eligibility criteria

Cancer type

Colorectal Cancer

Prior therapy

No prior treatment (treatment-naive required)

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT06940947 currently recruiting?

Yes, this trial is currently recruiting patients.

Can patients have received prior systemic therapy?

No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify

Colorectal Cancer trials